ConductScience.org, home

Paper31344348

Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.

Jiménez-Vacas JM and 14 others. Transl Res, 2019. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. Papers, record 31344348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31344348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.
PubMed
Journal
Transl Res
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
2.6
iCite
Revised in PubMed
2020-05-27
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiménez-Vacas JMJuan M
2Herrero-Aguayo VVicente
3Gómez-Gómez EEnrique
4León-González AJAntonio J
5Sáez-Martínez PPrudencio
6Alors-Pérez EEmilia
7Fuentes-Fayos ACAntonio C
8Martínez-López AAna
9Sánchez-Sánchez RRafael
10González-Serrano TTeresa
11López-Ruiz DJDaniel J
12Requena-Tapia MJMaría J
13Castaño JPJusto P
14Gahete MDManuel D
15Luque RMRaúl M

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Biomarkers, TumorMajor topic
PhosphoproteinsMajor topic
Prostatic NeoplasmsMajor topic
RNA Splicing FactorsMajor topic
Aged
Cell Line, Tumor
Cell Proliferation
Cohort Studies
Drug Delivery Systems
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Prognosis
Spliceosomes

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
42936122The long non-coding RNA LINC01089 facilitates prostate cancer progression.BBA Adv2026https://conductscience.org/library/papers/42936122PubMed
42716948Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.Nat Commun2026https://conductscience.org/library/papers/42716948PubMed
42649859The Role of Splicing Machinery as a Promising Potential Therapeutic Target for Pituitary Neuroendocrine Tumors (PitNETs).Cancers (Basel)2026https://conductscience.org/library/papers/42649859PubMed
42602702Pathophysiological and translational implications of the dysregulation of molecular machineries controlling RNA metabolism in thyrotropinomas.iScience2026https://conductscience.org/library/papers/42602702PubMed
42363275Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans.Orphanet J Rare Dis2026https://conductscience.org/library/papers/42363275PubMed
42103729Synergistic effect of Pladienolide B and cisplatin: enhancing autophagy in hepatoma cells through the AMPK/mTOR/ULK1 pathway.Cell Death Discov2026https://conductscience.org/library/papers/42103729PubMed
42013849Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients.Cell Rep Med2026https://conductscience.org/library/papers/42013849PubMed
41919503Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers.J Clin Invest2026https://conductscience.org/library/papers/41919503PubMed
41179739Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications.Bladder Cancer2025https://conductscience.org/library/papers/41179739PubMed
40581690Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets.Acta Neuropathol Commun2025https://conductscience.org/library/papers/40581690PubMed
39885614Targeting RNA splicing modulation: new perspectives for anticancer strategy?J Exp Clin Cancer Res2025https://conductscience.org/library/papers/39885614PubMed
39758250Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.Mol Ther Oncol2024https://conductscience.org/library/papers/39758250PubMed
39725737The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer.Cell Mol Life Sci2024https://conductscience.org/library/papers/39725737PubMed
39574470Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer.Oncol Res2024https://conductscience.org/library/papers/39574470PubMed
39356765SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer.Sci Adv2024https://conductscience.org/library/papers/39356765PubMed
39348093Defining Splicing Factor Requirements for Androgen Receptor Variant Synthesis in Advanced Prostate Cancer.Mol Cancer Res2024https://conductscience.org/library/papers/39348093PubMed
39275340The Protective Effects of an Aged Black Garlic Water Extract on the Prostate.Nutrients2024https://conductscience.org/library/papers/39275340PubMed
39127833The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11.Cancer Gene Ther2024https://conductscience.org/library/papers/39127833PubMed
39009593Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.Nat Commun2024https://conductscience.org/library/papers/39009593PubMed
39000035Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features.Int J Mol Sci2024https://conductscience.org/library/papers/39000035PubMed

See all 53 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
SF3B123451PubTator's text mininghttps://conductscience.org/library/genes/23451NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31344348

GET https://conductscience.org/api/papers/v1/31344348/cited_by?page=2